PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-15

  1. 470 Posts.
    lightbulb Created with Sketch. 61
    sorry to be extending this thread, but that's what i was thinking these companies might have to play with (billions) ..... so would it not be a fair gamble for them to place 60 to 100 million on the table now to beat the competition ?......i mean, quite a bit of the data and the medically based posters on here (including yourself), are very confident already about the probability of a successfull outcome.......surely then it would not be a difficult situation to place a bet ...(shall i put it)... on little old par.....especially if the potential is possible billions (?) in revenue later on ... I just don't get it obviously .....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
0.020(6.90%)
Mkt cap ! $120.7M
Open High Low Value Volume
29.0¢ 31.0¢ 28.0¢ $97.62K 331.4K

Buyers (Bids)

No. Vol. Price($)
2 74197 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 54675 2
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.